[Therapeutic strategies for the treatment of endocrine resistant hormone receptor positive advanced breast cancer].

Grellety, Thomas; Hajjaji, Nawale; Petit, Thierry; Bailleux, Caroline

[Therapeutic strategies for the treatment of endocrine resistant hormone receptor positive advanced breast cancer]. / Stratégies pour la prise en charge des cancers du sein métastatiques récepteurs hormonaux positifs hormonorésistants.

Grellety, Thomas; Hajjaji, Nawale; Petit, Thierry; Bailleux, Caroline.

Afiliação

Grellety T; Centre hospitalier de la Côte Basque, Bayonne, France. Electronic address: tgrellety@ch-cotebasque.fr.
Hajjaji N; Centre Oscar-Lambret, Lille, France; Laboratoire protéomique, réponse inflammatoire et spectrométrie de masse (PRISM), Inserm U1192, Lille, France.
Petit T; ICANS, Strasbourg, France.
Bailleux C; Centre Antoine-Lacassagne, Nice, France.

Bull Cancer ; 110(1): 69-87, 2023 Jan.

Article em Fr | MEDLINE | ID: mdl-36307325

Assuntos

Neoplasias da Mama; Humanos; Feminino; Neoplasias da Mama/genética; Receptores de Estrogênio; Fosfatidilinositol 3-Quinases/uso terapêutico; Resistencia a Medicamentos Antineoplásicos; Fulvestranto/uso terapêutico

Palavras-chave

Breast cancer; Cancer du sein; ESR1 mutation; Hormone resistance, CDK4/6 inhibitor; Hormonorésistance; Iinhibiteur de CDK4/6; Mutation ESR1; SERD

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: Fr Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google